Skip to content

A clinical trial to compare two different nasal interfaces for non-invasive ventilation support of preterm infants with respiratory distress in a tertiary care hospital

Randomized control trial comparing two different nasal interfaces for non-invasive ventilation support of preterm with respiratory distress syndrome in a tertiary care hospital

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/03/032409
Enrollment
250
Registered
2021-03-30
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: P229- Respiratory distress of newborn, unspecified

Interventions

Intervention1: RAM cannula: In the experimental group, RAM cannula will be used a nasal interface in a stand-alone Bubble CPAP device (Bubble CPAP system with F & P nasal interfaceâ??BC 163, Fisher an

Sponsors

Dr Anuj Bhatti
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Inborn babies with gestational age between 28weeks to 34weeks and birth weight more than or equal to 1000 g. 2) The presence of respiratory distress (presence of at least two out of three signs: tachypnoea > 60 per minute, intercostal retractions and expiratory grunt) within 6h of life requiring nasal CPAP.

Exclusion criteria

Exclusion criteria: 1) Intubation soon after birth 2) APGAR score 3) Life threatening malformations such as congenital diaphragmatic hernia, trachea- oesophageal fistula, and malformations that would prevent establishment of CPAP due to the anatomical defect such as Pierre- Robinson syndrome and choanal atresia. 4) Conditions where intubation and mechanical ventilation are directly indicated such as apnea and hypotensive shock.

Design outcomes

Primary

MeasureTime frame
Failure of CPAP within first 72 hrs of lifeTimepoint: first 72 hrs of life

Secondary

MeasureTime frame
Bronchopulmonary dysplasiaTimepoint: by 36 weeks post menstrual age;CPAP failureTimepoint: 7 days;Culture proven sepsisTimepoint: during the hospitalization;deathTimepoint: during hospital stay;Feeding intoleranceTimepoint: any time during hospitalization;Intraventricular hemorrhage (greater than grade 1)Timepoint: during hospitalization;Maximum CPAP pressure (cm H20)Timepoint: 72 hours;Nasal injury scoreTimepoint: 0-7;Necrotizing enterocolitisTimepoint: Stage 2 and 3 during hospitilization;Need for intubation and mechanical ventilationTimepoint: 72 hours of life;PneumothoraxTimepoint: during hospitalization;Pulmonary hemorrhageTimepoint: any time during hospitalization;Remained on CPAP by 7 days of ageTimepoint: 7 days;Remained on CPAP by 72 h of ageTimepoint: 72 hours;Surfactant (post randomization)Timepoint: hours;Suspected sepsisTimepoint: during hospitalization;Total duration of CPAP in hoursTimepoint: hours

Countries

India

Contacts

Public ContactDr Anuj Bhatti

Government Medical College, Jammu

bhatti.anuj@gmail.com9419221115

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026